Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9596 posts found.

covid_cell_1

Pharmafile.com’s weekly COVID-19 news round-up

July 29, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing COVID-19, coronavirus, pharma

The once-touted COVID cure hydroxychloroquine continues its downward spiral of credibility as new data is published on its lack of …
News
novartis_outside_1

Novartis’ Piqray combo becomes first Europe-approved therapy for PIK3CA-mutated advanced breast cancer

July 29, 2020 Research and Development, Sales and Marketing Europe, Novartis, Piqray, breast cancer, pharma

The European Commission (EC) has awarded its approval for Novartis’ Piqray (alpelisib) to be made available in combination with fulvestrant …
News
shutterstock_359806121

UK Government secures 60 million doses of Sanofi and GSK’s COVID-19 vaccine

July 29, 2020 Research and Development, Sales and Marketing COVID-19, GSK, Sanofi, UK government, pharma

The UK Government has sealed another deal to procure an effective COVID-19 vaccine for its citizens, partnering up with Sanofi …
News
roche

Roche’s Actemra fails to improve clinical status in COVID-19-associated pneumonia

July 29, 2020 Research and Development Actemra, COVID-19, Roche, pharma

Roche has announced the disappointing news that its therapy Actemra/RoActemra (tocilizumab) failed to improve clinical status to a statistically significant …
News

Yale-backed study to test efficacy of AI-selected therapy in COVID-19

July 28, 2020 Manufacturing and Production, Research and Development AI, COVID-19, clinical trial, pharma

Biopharma firm AI Therapeutics is partnering with Yale School of Medicine to launch a new clinical trial to identify the efficacy …
News
shutterstock_159488225

Farxiga smashes all goals in Phase 3 chronic kidney disease trial, says AstraZeneca

July 28, 2020 Manufacturing and Production, Research and Development AstraZeneca, farxiga

AstraZeneca has teased new data from a Phase 3 study of its sodium-glucose co-transporter-2 (SGLT2) inhibitor Farxiga (dapagliflozin) in the …
News
shutterstock_273326141

AstraZeneca partners with Daichii Sankyo in potential $6bn cancer drug deal

July 27, 2020 Research and Development, Sales and Marketing AstraZeneca, Daiichi Sankyo, partnership, pharma

AstraZeneca and Daiichi Sankyo have joined forces to drive the development and commercialisation of the latter’s DS-1062, a trophoblast cell-surface …
News
moderna_norwood_plant

US Government invests a further $472 million in Moderna’s BARDA-backed COVID-19 vaccine

July 27, 2020 Research and Development, Sales and Marketing COVID-19, Moderna, US government, Vaccine

Moderna has revealed a second investment of $472 million from the US Government’s Biomedical Advanced Research and Development Authority (BARDA) to support …
News
glenmark

Glenmark’s favipiravir accelerates viral clearance and clinical recovery in COVID-19 patients

July 24, 2020 Medical Communications, Research and Development COVID-19, coronavirus, favipiravir; Glenmark

The antiviral treatment favipiravir, in development from Glenmark Pharma, has shown promise as a potential COVID-19 therapy after hitting its …
News

UCB’s investigational IL-17A and IL-17F inhibitor outclasses Novartis’ Cosentyx in plaque psoriasis

July 24, 2020 Medical Communications, Research and Development Cosentyx, UCB, pharma, psoriasis

UCB has revealed promising new data from a head-to-head trial pitting the company’s IL-17A and IL-17F inhibitor bimekizumab against Novartis’ …
News
top_10_image_2_1

Top Ten most popular articles on Pharmafile.com this week

July 24, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing COVID-19, coronavirus, top 10, top 10 stories

As the coronavirus pandemic shows no signs of slowing down, an Israeli doctor has appeared to have contracted COVID-19 for …
News
meekey

David Meeker appointed Chief Executive Officer of Rhythm Pharmaceuticals

July 23, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Rhythm Pharmaceuticals have appointed David Meeker, M.D., as its Chief Executive Officer and President of the company. Meeker succeeds interim …
Appointment
shutterstock_244903099

UK Government invests £100m in new COVID-19 vaccine manufacturing site

July 23, 2020 Manufacturing and Production, Research and Development COVID-19, UK, Vaccine, coronavirus

The UK Government’s Department for Business, Energy & Industrial Strategy has revealed a new pledge of an additional £100 million …
News
winter_mask

Research suggests COVID-19 outcomes are worse in colder months

July 23, 2020 Research and Development COVID-19, coronavirus

A partnership between Chinese and European researchers has argued that the severity of COVID-19 could be worse in colder weather …
News
800px-smallpox_vaccine

Pfizer and BioNTech’s COVID-19 vaccine shows promise in another early stage study

July 22, 2020 Research and Development BioNTech, COVID-19, Pfizer, Vaccine, pharma

BioNTech and Pfizer have revealed more promising early data on their lipid nanoparticle formulated, nucleoside-modified messenger RNA vaccine candidate against …
News
The Gateway to Local Adoption Series

Latest content

Rhythm AI’s STAR Apollo system receives FDA clearance for atrial fibrillation

February 12, 2026

iOrganBio appoints Karol Jarzabek as Chief Operating Officer

February 12, 2026

Ensera Design expands UK leadership team with new senior appointments

February 11, 2026

Infinitopes announces $15.4m in additional seed funding to advance cancer vaccine

February 11, 2026

Angelini Pharma appoints Roberto Scrivo as Chief of External Affairs, Communication and Sustainability Officer

February 10, 2026